PV1115 is a potent and highly selective Chk2 inhibitor with an IC50 of 0.14 nM, 66000 nM, >100000 nM for Chk2, Chk1 and RSK2, respectively. PV1115 is situated within the ATP-binding pocket of Chk2[1].
References
[1] George T Lountos,
et al. Structural characterization of inhibitor complexes with
checkpoint kinase 2 (Chk2), a drug target for cancer therapy. J Struct Biol.
2011 Dec;176(3):292-301. DOI:10.1016/j.jsb.2011.09.008